Your browser doesn't support javascript.
loading
Uncovering the Potential of CD40 Agonism to Enhance Immune Checkpoint Blockade.
Wu, Richard C; Luke, Jason J.
Affiliation
  • Wu RC; The Ohio State University James Comprehensive Cancer Center and Division of Medical Oncology, Columbus, Ohio.
  • Luke JJ; UPMC Hillman Cancer Center and the University of Pittsburgh Department of Medicine, Pittsburgh, Pennsylvania.
Clin Cancer Res ; 30(1): 9-11, 2024 01 05.
Article in En | MEDLINE | ID: mdl-37870487
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD40 Antigens / Immune Checkpoint Inhibitors Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD40 Antigens / Immune Checkpoint Inhibitors Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2024 Document type: Article Country of publication: